As Seen In...
-
Investor backing sought for ovine collagen company
Read articleOtago Daily Times and Rural Life – June 2024
Christchurch-based Everee Women™ is seeking investment to scale its world-first ovine collagen innovation, Ovitage®, developed to support women through peri- and post-menopause. -
New Zealand’s agriculture innovation stars revealed
Read articleNational Business Review – June 12, 2025
The winners of the annual Fieldays Innovation Awards were unveiled, spotlighting leading agritech startups shaping Aotearoa’s future—even as concerns rise over the closure of Callaghan Innovation and its impact on commercialisation support -
Dr Rob Kelly - The world's most complete collagen
LISTEN TO INTERVIEWRural Exchange - June 11, 2025
Dom talks with Dr Rob Kelly, Chief Scientific Officer at TEO, about its Ovitage product, a bioactive protein made from sheep and lamb skins that would otherwise go to landfill, its unique amino acid profile and its Everee Women range.
-
Fieldays spotlight: Christchurch start‑up’s sheepskin collagen powder
Read ArticleRadio New Zealand (RNZ) – June 11, 2025
Christchurch biotechnology start‑up Tertiary Extracts Ōtautahi is transforming waste sheepskins into a world‑first collagen powder, Ovitage®, showcased at Fieldays and making waves in the global health and wellness market
-
Fieldays 2025: Christchurch start-up turns sheepskin into collagen powder
Read ArticleNZ Herald – June 10, 2025
Christchurch biotech company Tertiary Extracts Ōtautahi is transforming discarded sheepskins into Ovitage®, a novel collagen powder showcased at Fieldays 2025. This world‑first innovation harnesses NZ sheep by‑product, offering a sustainable, high‑value option for health and wellness markets both here and abroad
-
Christchurch biotech company seeking investors
Read ArticleOtago Daily Times – June 2025
Christchurch-based Tertiary Extracts Ōtautahi (TEO) is launching a capital raise to scale production of its innovative ovine collagen, Ovitage®, which repurposes over 550 tonnes of waste sheepskins annually into high-value ingredients for health, supplement, and personal-care markets. After early sales in the US and a tailored menopause supplement range under Everee Women™, TEO is eyeing expansion into Europe and Asia—and is open to strategic investment to support new market entry and further scientific development
Media Enquiries
Want to learn more about Everee Women™, Ovitage®, or our innovation journey? We’re happy to provide interviews, expert commentary, product information, and imagery for your story.
Let’s chat – we’d love to hear from you.
Email Us